Archive for January, 2021

The 65 rating InvestorsObserver gives to Crispr Therapeutics AG (CRSP) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 80 percent of stocks in the Biotechnology industry, CRSPs 65 overall rating means the stock scores better than 65 percent of all stocks.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 65 would rank higher than 65 percent of all stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

Crispr Therapeutics AG (CRSP) stock is down -4.15% while the S&P 500 is higher by 0.12% as of 10:57 AM on Tuesday, Dec 29. CRSP is down -$7.01 from the previous closing price of $168.93 on volume of 2,016,389 shares. Over the past year the S&P 500 has risen 16.09% while CRSP is higher by 161.84%. CRSP lost -$3.25 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Crispr Therapeutics AG (CRSP) Stock.

Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.

You May Also Like

View original post here:
Should Crispr Therapeutics AG (CRSP) be in Your Portfolio? - InvestorsObserver

Here with your Southeast Regional Ag Report, Im Tim Hammerich.

Its nearly impossible to talk about the Florida citrus industry in 2020, without at least mentioning citrus greening disease. Otherwise known as huanglongbing, citrus greening is spread by the asian citrus psyllid which serves as a vector for the disease.

Citrus greening has done enormous damage to the Florida citrus industry despite years of research to try to develop effective management tools. Scientists are now hopeful that CRISPR can help. The tool for editing genomes, allows breeders to select for very specific traits, and iterate more quickly.

And they have a roadmap to follow. CRISPR has been used to develop resistant varieties to citrus canker. A program started in 2013 was able to identify the citrus canker susceptibility gene in 2014, and through CRISPR found a way to knock out this susceptibility gene. They have now made, this year, citrus varieties that are resistant to citrus canker.

Dr. Nian Wong, professor at the Citrus Research at Education Center for the University of Florida IFAS at Lake Alfred, says they were able to make progress on citrus canker much quicker than traditional breeding, and he hopes this can also be applied to citrus greening.

While there can be no guarantees on timing, Dr. Wong hopes that progress can be made on citrus greening on a similar timeline to what theyve been able to do these past seven years with citrus canker.

Original post:
Can CRISPR Save Florida Citrus? - AG INFORMATION NETWORK OF THE WEST - AGInfo Ag Information Network Of The West

Apart from new findings on coronavirus every single day, the year was also filled with stories from outer space, archeology and anatomy

The year 2020 also termed as the year of the pandemic, social distancing, work from home, was also the year of research at breakneck speed. Virologists, immunologists, computational biologists, epidemiologists, and medical professionals across the globe turned into superheroes without capes.

Quick sequencing of the whole genome of the novel coronavirus (SARS-CoV-2) helped develop various test kits. We now have not one or two, but multiple COVID-19 vaccines that have succeeded in human clinical trials. Moderna's and Pfizer-BioNTechs vaccines that use messenger RNA have reported efficacy of about 95%, and the United Kingdom, the United States and the United Arab Emirates have already launched mass vaccinations.

Apart from new findings on coronavirus every single day, the year was also filled with stories from outer space, archeology and anatomy. Here is a list of a few of them in random order

In October, NASA confirmed, for the first time, water on the sunlit side of the Moon indicating that water may be distributed across the moons surface, and not limited to the cold and shadowed side.

Researchers from the Netherlands Cancer Institute announced in October that they have discovered a new pair of salivary glands hidden between the nasal cavity and throat. The team proposed the name tubarial glands and noted that this identification could help to explain and avoid radiation-induced side-effects such as trouble during eating, swallowing, and speaking.

In September, an international scientific team announced that they have spotted phosphine gas on Venus. On Earth, microorganisms that live in anaerobic (with no oxygen) environments produce phosphine. Massachusetts Institute of Technology molecular astrophysicist and study co-author Clara Sousa-Silva said in a release, This is important because, if it is phosphine, and if it is life, it means that we are not alone. It also means that life itself must be very common, and there must be many other inhabited planets throughout our galaxy.

Read our detailed explainer here.

In March, a person suffering from Leber congenital amaurosis, a rare inherited disease that leads to blindness, became the first to have CRISPR/Cas-9-based therapy directly injected into the body.

In June, two patients with beta-thalassemia and one with sickle cell disease had their bone marrow stem cells edited using CRISPR techniques.

Click here to read our explainer on the genome-editing tool that won this years Nobel Prize for Chemistry.

The year 2020 marks 100 years of discovery of Indus Valley Civilisation, and a new study showed that dairy products were being produced by the Harappans as far back as 2500 BCE.

Another study found the presence of animal products, including cattle and buffalo meat, in ceramic vessels dating back about 4,600 years.

Chinas Change-5 probe brought back about 1,731 grams of samples from the moon becoming the third country to bring moon samples after the U.S and Soviet Union.

Also, Japans Hayabusa 2 brought back the first extensive samples from an asteroid. The spacecraft, launched from Japan's Tanegashima space centre in 2014, took four years to reach the asteroid Ryugu before taking a sample and heading back to Earth in November 2019.

Mars rover Perseverance blasted off for the red planet on July 30 to bring the first Martian rock samples back to Earth. If all goes well, the rover will descend to the Martian surface on February 18, 2021.

You have reached your limit for free articles this month.

Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.

Enjoy reading as many articles as you wish without any limitations.

A select list of articles that match your interests and tastes.

Move smoothly between articles as our pages load instantly.

A one-stop-shop for seeing the latest updates, and managing your preferences.

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

Excerpt from:
2020: The year science took centre-stage - The Hindu

For obvious reasons, 2020 will not go down as a good year. At the same time, it has brought more scientific progress than any year in recent memory and these advances will last long after COVID-19 as a major threat is gone.

Two of the most obvious and tangible signs of progress are the mRNA vaccines now being distributed across America and around the world. These vaccines appear to have very high levels of efficacy and safety, and they can be produced more quickly than more conventional vaccines. They are the main reason to have a relatively optimistic outlook for 2021. The mRNA technology also may have broader potential, for instance by helping to mend damaged hearts.

Other advances in the biosciences may prove no less stunning. A very promising vaccine candidate against malaria, perhaps the greatest killer in human history, is in the final stages of testing. Advances in vaccine technology have created the real possibility of a universal flu vaccine, and work is proceeding on that front. New CRISPR techniques appear on the verge of vanquishing sickle-cell anemia, and other CRISPR methods have allowed scientists to create a new smartphone-based diagnostic test that would detect viruses and offer diagnoses within half an hour.

It has been a good year for artificial intelligence as well. GPT-3 technology allows for the creation of remarkably human-like writing of great depth and complexity. It is a major step toward the creation of automated entities that can react in very human ways. DeepMind, meanwhile, has used computational techniques to make major advances in protein folding. This is a breakthrough in biology that may lead to the easier discovery of new pharmaceuticals.

One general precondition behind many of these advances is the decentralized access to enormous computing power, typically through cloud computing. China seems to be progressing with a photon method for quantum computing, a development that is hard to verify but could prove to be of great importance.

Computational biology, in particular, is booming. The Moderna vaccine mRNA was designed in two days, and without access to COVID-19 itself, a remarkable achievement that would not have been possible only a short while ago. This likely heralds the arrival of many other future breakthroughs from computational biology.

It also has been a good year for progress in transportation.

Driverless vehicles appeared to be stalled, but Walmart will be using them on some truck deliveries in 2021. Boom, a startup that is pushing to develop feasible and affordable supersonic flight, now has a valuation of over $1 billion, with prototypes expected next year. SpaceX achieved virtually every launch and rocket goal it had announced for the year. Toyota and other companies have announced major progress on batteries for electric vehicles, and the related products are expected to debut in 2021.

All this will prove a boon for the environment, as will progress in solar power, which in many settings is as cheap as any relevant alternative.

In previous eras, advances in energy and transportation typically have brought further technological advances, by enabling humans to conquer and reshape their physical environments in new and unexpected ways. We can hope that general trend will continue.

Finally, while not quite meeting the definition of a scientific advance, the rise of remote work is a real breakthrough. Many more Zoom meetings will be held, and many business trips will never return. Many may see this as a mixed blessing, but it will improve productivity significantly.

Without a doubt, it has been a tragic year. Alongside the sadness and failure, however, there has been quite a bit of progress. Thats something worth keeping in mind, even if we cant quite bring ourselves to celebrate, as we look back on 2020.

Tyler Cowen is a syndicated columnist.

Follow this link:
2020 was a tough year, but there is a silver lining - Boston Herald

The "Genetic Testing. Global Market Forecasts for Applications and Technologies. Updated for COVID-19 Pandemic Impact with Executive and Consultant Guides 2021 to 2025" report has been added to ResearchAndMarkets.com's offering.

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry.

The traditional genetic testing market is growing in volume and growing in the breadth of tests creating a new life for the industry. The report forecasts the market size out to 2025. The report includes detailed breakouts for 14 countries and 5 regions.

Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

Companies Mentioned

10x Genomics, Inc

23andME Inc

Abbott Diagnostics

AccuraGen Inc

Adaptive Biotechnologies

Admera Health, LLC

Agena Bioscience, Inc

Agilent

Akonni Biosystems

Ancestry.com LLC

Anchor Dx

ArcherDx, Inc

ARUP Laboratories

Asuragen

Baylor Miraca Genetics Laboratories

Beckman Coulter, Inc

Becton, Dickinson and Company

BGI Genomics Co. Ltd

Bio-Rad Laboratories, Inc

Bio-Techne

Bioarray Genetics

Biocept, Inc

Biodesix Inc

BioFluidica

BioGenex

Biolidics Ltd

bioMerieux Diagnostics

Bioneer Corporation

Cancer Genetics

Caris Molecular Diagnostics

CellMax Life

Centogene

Chronix Biomedical

Circulogene

Clinical Genomics

And Many More Companies!

1. Introduction and Market Definition

1.1 Genetic Testing Definition in This Report

1.2 The Genomics Revolution

1.3 Market Definition

1.3.1 Revenue Market Size

1.3.1 Newborn Screening

1.3.2 Non Invasise Pregnancy Testing

1.3.3 Predictive

1.3.4 Oncology

Story continues

1.3.5 Direct to Consumer

1.3.6 Other Application

1.3.7 PCR

1.3.4 NGS

1.3.5 Cytogenetic

1.3.6 Other Technology

1.4 U.S. Medical Market and laboratory Testing - Perspective

1.4.1 U.S. Medicare Expenditures for Laboratory Testing

2. Market Overview

2.1 Market Participants Play Different Roles

2.1.1 Supplier/pharmaceutical

2.1.2 Independent lab specialized/esoteric

2.1.3 Independent lab national/regional

2.1.4 Independent lab analytical

2.1.5 Public National/regional lab

2.1.6 Hospital lab

2.1.7 Physician lab

2.1.8 DTC Lab

2.1.9 Independent Genetic Testing Lab

2.1.10 Audit Body

2.2 Genetic Tests -Types, Examples and Discussion

2.2.1 Preimplantation Genetic Diagnosis- An Emerging Market

2.2.2 Prenatal Diagnosis - New Technologies Create Opportunity

2.2.3 Newborn Screening

2.2.2 Diagnostic Testing

2.2.3 Carrier Testing

2.2.6 Predictive and Presymptomatic Testing

2.2.7 Pharmacogenomics

2.2.8 Forensic Testing

2.2.9 Parental Testing

2.2.10 Ancestral Testing

2.3 Industry Structure

2.3.1 Hospital's Testing Share

2.3.2 Economies of Scale

2.3.2.1 Hospital vs. Central Lab

2.3.3 Physician Office Lab's

2.3.4 Physician's and POCT

2.4 Market Shares of Key Genetics Players - Analysis

3. Market Trends

3.1 Factors Driving Growth

3.1.1 Genetic Discoveries Creating New Diagnostic Markets

3.1.2 Aging Population a Boon for Diagnostics

3.1.3 Pharmacogenomics Drives Further Growth

3.1.4 Oncology and Liquid Biopsy Enter New Era

3.1.5 Fertility Practice Growth drives market

3.1.6 Direct to Consumer begins to break out

3.2 Factors Limiting Growth

3.2.1 Increased Competition Lowers Price

3.2.2 Lower Costs

Read more from the original source:
Global Genetic Testing Market Forecasts for Applications and Technologies to 2025 - ResearchAndMarkets.com - Yahoo Finance

This article was originally published here

Clin Gastroenterol Hepatol. 2020 Dec 24:S1542-3565(20)31721-3. doi: 10.1016/j.cgh.2020.12.025. Online ahead of print.

ABSTRACT

BACKGROUND AND AIMS: Up to 20% of younger patients (age <50 years) diagnosed with colorectal cancer (CRC) have germline mutations in cancer susceptibility genes. Germline genetic testing may guide clinical management and facilitate earlier intervention in affected relatives. Few studies have characterized differences in genetic testing by race/ethnicity.

METHODS: We identified young adults (age 18-49 years) diagnosed with CRC between 2009 and 2017 in two health systems in Dallas, TX. We evaluated referral to genetic counseling, attendance at genetic counseling appointments, and receipt of germline genetic testing by race/ethnicity.

RESULTS: Of 385 patients with young-onset CRC (median age at diagnosis 44.4 years), 176 (45.7%) were Hispanic, 98 (25.4%) non-Hispanic Black, and 111 (28.8%) non-Hispanic White. Most patients (76.9%) received immunohistochemistry (IHC) for mismatch repair proteins, and there was no difference in receipt of IHC by race/ethnicity. However, a lower proportion of Black patients were referred to genetic counseling (50.0% vs. White patients 54.1% vs. Hispanic patients 65.9%, p=0.02) and attended genetic counseling appointments (61.2% vs. 81.7% White patients vs. 86.2% Hispanic patients, p<0.01). Of 141 patients receiving genetic testing, 38 (27.0%) had a pathogenic or likely pathogenic variant in a cancer susceptibility gene. An additional 33 patients (23.4%) had variants of uncertain significance, of which 84.8% occurred in racial/ethnic minorities.

CONCLUSION: In a diverse population of patients diagnosed with young-onset CRC, we observed racial/ethnic differences in referral to and receipt of germline genetic testing. Our findings underscore the importance of universal genetic testing to address racial/ethnic disparities in young-onset CRC.

PMID:33359728 | DOI:10.1016/j.cgh.2020.12.025

Read more here:
Racial and ethnic disparities in germline genetic testing of patients with young-onset colorectal cancer - DocWire News

In August 2020, the FDA approved the first diagnostic test that combines next-generation sequencing and liquid biopsy. The test is intended to help guide treatment decisions for patients with specific types of mutations of the epidermal growth factor receptor (EGFR) gene in metastatic nonsmall cell lung cancer (NSCLC), which is particularly deadly. The FDA called it a new era for mutation testing. The approval was granted to Guardant360CDx to provide information on multiple solid tumor biomarkers and to help identify EGFR mutations in patients who will benefit from treatment with osimertinib (Tagrisso), which is approved for a form of metastatic NSCLC.

Read the full article here.

4. Dr Andre Goy Discusses What Weve Learned About CAR T Therapies and Cytokine Responses

In a video interview, Andre Goy, MD,chairman, director, and chief of the Division of Lymphoma at John Theurer Cancer Center in Hackensack, NJ,discussed what has been learned from existing chimeric antigen receptor T (CAR T)-cell therapies in managing cytokine responses.

Watch the interview here.

3. OneOncology, Foundation Medicine Create Partnership to Deliver Targeted Care

Also in August 2020, OneOncology, a network of nearly 170 community oncology care sites, and cancer genomic profiling firm Foundation Medicine announced a partnership to give patients and physicians access to genomic profiling tools as well as expanded research opportunities. In addition, OneOncology will help Foundation Medicine to create new assays for community oncology practices.

Read the full article here.

2. Broad Testing for Multiple Genes Benefits Patients With Cancer, Relatives

A study published in JAMA Oncology described how universalmultigene panel testingwas linked with increased detection of actionable, heritable variants beyond what one would expect to find using targeted genetic testing based on current cancer guidelines. The multicenter cohort study found that 1 in 8 patients had a pathogenic germline variant, half of which would not have been found if using guidelines alone. In addition, for the nearly 30% of patients with a high-penetrance variant, the findings led to a change in treatment.

Read the full article here.

1. How DNA Medicines Could Transform Treatment of Glioblastoma Multiforme

In an article appearing in the August 2020 edition of Evidence-Based Oncology, Jeffrey Skolnick, MD, the vice president of clinical development at biotech firm Inovio, discusses the companys proprietary technology that uses a computer algorithm to build DNA medicines that can target almost any antigen that can be presented to the human immune system through the major histocompatibility class I system. DNA medicines are built in the form of circular strands of synthetic DNA called plasmids, which can neither propagate nor integrate into the human genome. He also discusses their use in a potential application for glioblastoma, which is incurable.

Read the full article here.

Visit link:
The Top 5 Most-Read Precision Oncology Articles of 2020 - AJMC.com Managed Markets Network

New Year's celebrations are likely to look a lot different this year than most, as many people heed warnings to steer clear of mass gatherings during the global COVID-19 pandemic. Wall Street also seems to have had some cold water thrown on what was otherwise an extremely strong year for the stock market, as major market benchmarks are down at midday on New Year's Eve. As of noon EST, the Dow Jones Industrial Average (DJINDICES:^DJI) was down 39 points to 30,370. The S&P 500 (SNPINDEX:^GSPC) lost 3 points to 3,729, and the Nasdaq Composite (NASDAQINDEX:^IXIC) eased lower by 36 points to 12,834.

Yet even with the markets losing ground, several of the year's best-performing individual stocks kept up their momentum. Shares of Fulgent Genetics (NASDAQ:FLGT) and Celsius Holdings (NASDAQ:CELH) have already soared in 2020, but investors were willing to put more money to work and send their share prices still higher on the final day of the year.

FLGT data by YCharts.

Shares of Fulgent Genetics were up more than 10% on Thursday at midday. The genetic testing and diagnostics company has gotten a lot of business from the pandemic, and Fulgent continues to pull in customers and demonstrate its value to shareholders.

Fulgent found itself in the right place at the right time in 2020, with its quick work in coming up with coronavirus tests leading to an at-home sample-collection kit that received approval from the U.S. Food and Drug Administration in June. The company's third-quarter revenue skyrocketed as a result, topping the $100 million mark after doing just $10 million in business in the same period of 2019.

Image source: Getty Images.

Some fear that now that coronavirus vaccines are available, Fulgent will see its COVID-19 testing fall off a cliff. However, with the rollout of vaccines going at a slower pace than many had hoped for, there'll still be plenty of need for coronavirus tests well into 2021. And more importantly, with Fulgent having demonstrated its ability to respond quickly in a crisis, the company has made valuable contacts in the healthcare and insurance industries that should serve to produce further growth opportunities in the years to come.

Fulgent has more than quadrupled investors' money in 2020. It might not jump another 300% or more in 2021, but the genetic-testing specialist has plenty of chances to keep its stock moving higher.

Shares of Celsius Holdings fared even better, rising more than 13% at midday. That's consistent with what's been an amazing year for the energy-drink specialist, with its stock jumping to more than 10 times where it started the year.

The latest surge for Celsius came as a result of a move from index managers at S&P Dow Jones Indices. Celsius will join the S&P SmallCap 600 Index effective as of Jan. 7. The move stems from an acquisition involving a company in the S&P 500, which created a cascade effect that eventually created a vacancy in the small-cap index.

Celsius joined a highly competitive arena with its energy drinks, but the company's focus on fitness and performance resonated well with consumers. Revenue has jumped more than fivefold in less than four years, and Celsius turned profitable in 2019 and has managed to maintain its bottom-line strength, even in the difficult current environment. That's a big part of what's attracting attention for the company, and it holds the key to Celsius' future success.

Investors must not get used to seeing stocks climb 300%, 500%, or even 1,000% in a year. However, when it happens, it often signals strength that will continue. Investors should expect to see more good things from Celsius and Fulgent in 2021.

Continued here:
Stock Markets Sink, but These 2020 Stock Winners Look Good for the New Year - The Motley Fool

Take a deep breath 2020 is over and a new year has just begun. After months of fear caused by the Covid-19 pandemic, its time to turn the page, look ahead and start taking care of yourself. And weve got all the info you need to do just that. From enrolling in a Zoom fitness class to consulting with a genetic counselor, weve compiled dozens of ways for you to make 2021 your healthiest, and best, year ever.

For local fitness instructors, offering workout routines through Zoom or other video platforms has been a godsend during the pandemic. The technology allows them to reach clients who dont feel comfortable coming to the gym, and it also makes it harder to wiggle out of a workout. Running late and dont have time to drive to the gym? That excuse wont cut it anymore.

Many local fitness studios, like Chica Boom Fitness and Anytime Fitness, have begun offering workouts on Zoom or Facebook. Local trainers will guide you through daily workouts that mix weight training for specific muscle groups and both high- and low-impact cardio workouts.

Some even offer creative substitutions if you lack the necessary workout gear at home. Dont have kettlebells? Grab two full gallon water jugs instead. Dani Williams, who owns Nxt Generation, a fitness company that offers classes at the Sarasota studio Definition Fit, says Zoom classes offer flexibility for both the trainer and the client.

Williams works primarily with children and young adults, many of whom have special needs. Remote classes make it easier for them to show up each week, wherever they are. Travel is a big thing that prevents people from keeping a routine, says Williams. Its a really nice feature to have.

Even once the pandemic passes, Williams thinks remote fitness lessons will only grow in popularity. Local athletes can train with coaches all over the world, and local trainers can reach customers anywhere. Ive found great success with it, Williams says. Cooper Levey-Baker

Sarasota counselor Audrey Oxenhorn says committing to regular appointments with a therapist can make a huge difference in ones mental health, but the real work happens in between those meetings. An hour a week is never enough, says Oxenhorn.

To help people stay on track, Oxenhorn often recommends The Tapping Solution, an app that guides people as they tap on specific acupressure points on their body. The tapping, combined with calming sounds and words, is intended to reduce stress and anxiety. The app relies on a method that has been around for decades, but it has made it more accessible for millions of people. The technique and the app dont work for all of Oxenhorns clients. But when it does, its spectacular, she says.

The Tapping Solution is only one of dozens of apps that offer guided meditations and other programs that target anxiety, stress, fear, anger and other negative emotions. Headspace, for example, claims it has more than 65 million users in 190 countries, and has partnered with major companies like Nike and Starbucks. Other popular options include Moodfit, Sanvello and Happify.

According to Oxenhorn, apps make it easier for people struggling with mental health to take that first difficult step toward getting help and they give them tools to improve their mental health outside of a therapists office. I especially want to teach people to do the work themselves, so they can be happier and more fulfilled in what they do, Oxenhorn says. Cooper Levey-Baker

More and more people who have trouble falling, and staying, asleep are turning to melatonin, but does it work? According to Dr. Glenn Adams, a sleep medicine specialist and the medical director for Sarasota Memorials Sleep Disorder Center, the answer is: sometimes, for some people.

Melatonin is a naturally occurring substance in humans. Levels typically rise when it gets dark, cueing our bodies that its time for sleep. But as we grow older, our bodies produce less. At a young age, we have more than enough melatonin, says Adams. When youre 20 or 30, any benefits of taking it will be placebo.

Adams says there are no rigorous studies about melatonins benefits, but some do show that it may help you fall asleep 15 minutes sooner. That might help if it normally takes you 30 minutes to fall asleep, but if it usually takes you two hours, the benefit may be minimal.

With over-the-counter melatonin, the customer doesnt know exactly how many milligrams of melatonin he or she is getting, so Adams recommends sticking with the same brand for a consistent dosage. Side effects can be occasional nightmares, or even feeling a bit hungover when you wake up in the morning. If you do try melatonin, Adams says that once or twice is not enough to see if its working. Give it longer. Kay Kipling

Beet juice is the latest superfood to gain widespread attention, and whats not to like? Its low in caloriesone cup of beet juice has just 100 caloriesand its full of nitrates that improve your blood flow and help lower your blood pressure. According to one national study, people who drank beet juice for six days had better stamina to exercise more intensely.

Thats why its such a great pre-workout juice, says Lynn Morris, the owner of SaraFresh, which recently opened a retail store in the Rosemary District. SaraFresh specializes in cold-pressed juices, which have more nutritional value than pasteurized juices you find in the grocery store.

Morris says her new crowd favorite is something she calls Beetiful, a blend of beet, apple, lime and ginger, and she also offers 2.5-ounce beet shots. Shes also adding beet juice to her La Vie En Rose vegan ice cream to give it its signature rose color. By the way, dont panic if, after drinking beet juice, your urine turns reddish. Thats perfectly normal. Ilene Denton

Telemedicine has been around for years, but the Covid-19 pandemic has caused a massive rise in the number of doctors who offer consultations over the phone or through apps. But physicians cant take your vitals over the phone, so, more and more, they are relying on clients equipping themselves with tools to monitor their own data.

QardioArm, for example, is a home blood pressure monitor that delivers results to your phone and can share your numbers directly with your physician. Withings, meanwhile, is a smart scale that can also measure your bone, muscle and fat mass, and even adjusts for different gravity levels where you live to accurately determine your weight. Pulse oximeters that measure the oxygen level in your blood have also been flying off the shelves since the arrival of the coronavirus, as have affordable no-touch thermometers that read your temperature by scanning your forehead. Cooper Levey-Baker

At Scorch Fitnesswhich specializes in HIIT, or high-intensity interval traininga typical in-person session might last 45 to 50 minutes. But even workouts as short as 10 minutes can yield results, says Scorch owner Liz Lowe. Such brief sessions are known as micro HIIT workouts and are done at your own home. No instructor is needed. Just pick a combination of workouts (squats, a forearm plank and mountain climbers, for example) and get to work.

Micro HIIT workouts have become an increasingly popular way for people to squeeze in a good sweat between Zoom meetings, picking up the kids and running errands. I think micro HIIT is great for people who are strapped for time or if youre just getting into training, Lowe says.HIIT works by combining aerobic and anaerobic exercises that get your heart rate soaring, then alternating those with shorter periods of less strenuous activity. The Scorch program was adapted from workouts Lowe created for professional athletes, and it is designed to help you simultaneously burn body fat, add muscle and increase your resting metabolism. Micro HIIT exercises do the same thing, just in briefer windows of time.

If youre interested in trying them, Lowe recommends starting by finding exercises that just use your body weight. If you reach a point where you want to begin using weights, she recommends consulting with a trainer to make sure your form is correct. The last thing you want to do is get injured, Lowe says. Cooper Levey-Baker

When people talk about gut health, theyre not just talking about your stomach. The term gut refers to your whole gastrointestinal tract, which is covered in trillions of microscopic living organisms that help regulate a host of bodily systems, including immunity and weight.

But maintaining a healthy gut isnt always easy. Tens of millions of Americans suffer from digestive conditions like irritable bowel syndrome, nausea, bloating and constipation.

Gastroenterologist Nihar Shah of First Physicians Group says you can keep your gut healthy by eating foods rich in pre- and probiotics, such as apples, garlic, sweet potatoes, oats, chia seeds, onions, berries, kimchi, pickles, sauerkraut and yogurt. Shah also recommends colonoscopies once every 10 years once you reach 50 to screen for colon cancer. A healthy gut can play a role in preventing that, too.

Theres a direct link between colon cancer and consuming red meat and processed meat, so I recommend decreasing both of those things, as well as processed and genetically modified foods, says Shah. Also important: maintaining a healthy weight, getting a good nights sleep and exercising regularly.

And if youre taking any antibiotics, make sure to supplement your diet with those probiotic-rich foods, which can wipe out the good bacteria thats so important to a healthy gut. Megan McDonald

Over the last 20 years, genetic testing has emerged as a valuable tool for analyzing and even mitigating all kinds of medical conditionsincluding cancer. But testing is more road map than crystal ball. Nothing is definite. Everything is just about risk, says Nicole Wood, the oncology genetic counselor for Sarasota Memorials Genetic Testing for Hereditary Cancer program.

The genetic testing process begins with an extensive conversation with a genetic counselor, who will ask about your own medical history as well as your familys. If you opt for a genetic test, it only requires a blood draw.

[Your genetic makeup] is not new. Its something youve always carried since birth, says Wood. We use it to modify what were doing with your cancer care, screening, medical management, etc. Whatever train youre on that might lead to cancer, we can redirect it.

Still, genetic testing isnt for everyone, and theres good reason not to rush out and get tested willy-nilly. Once you know this information, you cant un-know it, says Wood.

Genetic testing technology continues to evolve at warp speed. Wood estimates that the number of genes that can be tested for cancer risk will double in two years. Wood even sees the probability of genetic manipulation in the future. Can we change these genes? she asks. Maybe." Hannah Wallace

Fitness experts say switching up your workouts is a good thing. You wont risk repetitive injuries and youll stimulate your brain at the same time. Foil boarding, a combination of windsurfing and wakeboarding, fits the bill.

Foil boarding starts with the hydrofoil, a wing-like structure that extends below the board into the water and lifts the board up so the rider looks like she (or he) is soaring a couple of feet above the water. This propeller allows riders to achieve speeds six knots faster than recorded gusts on a windy day. Add a parachute, and riders can really fly. The sport has become popular along the Gulf Coast, where youll spot riders levitating and landing tricks.

If youre looking to give it a try, you can purchase a board from the Venice board-making company Phase Five. The company has three different boards to choose from: the Gizmo ($1,270), the Chip ($1,270) and the Gadget ($989), which range from 44 to 54 inches long. Beginners should start with a longer board and foot straps to assist with training. Experienced surfers can try out shorter boards to glide through the air and land tricks. Allison Forsyth

Go here to read the rest:
How to Make 2021 Your Healthiest Year Yet - Sarasota

Genetics is a high tech, research-intensive business. Between the complexity of the science and the demands of the clinical trials and regulatory approval process, it's also quite risky -- but the rewards can be immense.

Many genetics companies spent the year working on the projects that might become their first sources of revenue. The market reacted to their every peep, and there's a good chance that several of these stocks will have another bumper crop year in 2021.

Image source: Getty Images.

Selling coronavirus diagnostic tests is big business, as shown by the 990% rise of Co-Diagnostics (NASDAQ:CODX) this year. With quarterly revenue growth exceeding 52,559% year over year, it's easy to see why the market was so enthusiastic about the company. Moving forward, it will penetrate foreign markets like India, selling tens of millions of its molecular test kits in the process.

Furthermore, Co-Diagnostics is moving quickly to develop new genetic tests that can detect viral mutations for the laboratory research market, ensuring that it will stay relevant through next year and beyond. Investors should look forward to another great year in 2021, with the caveat that it'll be tough to grow nearly as quickly as it did this year now that the testing market is significantly more crowded with competitors.

Arcturus Therapeutics (NASDAQ:ARCT) surged nearly 300% in 2020 by advancing its mRNA-based coronavirus vaccine program, which should enter phase 2 of its clinical trials in the first quarter of 2021. Though its candidate isn't as closely watched as several of the other leading contenders, there's a lot riding on its success. Like many biotech companies, it doesn't have any products on the market or any recurring revenue to speak of. That might change next year if its vaccine is proven effective. But, the early signs don't look good. A recent clinical update showed that its candidate might not be as protective as the other mRNA vaccines that are already approved for sale.

Investors can take heart in the fact that with just over $307 million in cash, Arcturus has enough gas in the tank to explore a few options for boosting the vaccine's efficacy. Until then, they can sit pretty on the stock's growth this year. If you're interested in investing, the only thing to do at the moment is to watch for clinical trial updates to see how its core project is advancing.

Given how many hopes were riding on its coronavirus vaccine candidate, you shouldn't be surprised to see Moderna (NASDAQ:MRNA) on this list. With growth of around 467%, Moderna will likely turn a profit for the first time next year as its vaccines are sold at mass scale. But, its stock may not be able to keep up with the valuations that 2020 built with hype.

Whether its first earnings reports in the new year will herald a reckoning is anyone's guess. Nonetheless, in the long-term its older pipeline projects will start to come to fruition. Some of those have the potential to be hugely disruptive, like its personalized cancer vaccine collaboration with Merck. Others, like its cytomegalovirus vaccine, may not make a big splash. Investors should watch the company's pipeline updates carefully, not to mention its earnings reports. There's every indication that its vaccine will be a big moneymaker, potentially to the tune of $32 billion in 2021. So, the real question is: What management will choose to spend the windfall on?

CODX data by YCharts

Inovio Pharmaceuticals (NASDAQ:INO) grew by 173% this year thanks to its coronavirus vaccine program. Like Moderna, Inovio's pipeline also has a smattering of lesser-known vaccines in development, none of which garnered the market's attention very much. Until this year, that is. Once the U.S. government's vaccine accelerator program invested in Inovio, it quickly entered the spotlight.

There's reason to be excited about Inovio moving forward, too. In mid-December, it announced that the government had taken an interest in developing a DNA-encoded monoclonal antibody therapy for COVID-19 using the company's technology. Likewise, its vaccine administration device developed with public funding may be key to its future success. Still, its coronavirus programs need to be proven definitively in clinical trials next year if its stock is to grow any further, and doubts remain about the viability of its DNA-based vaccines.

Thanks to hot demand for its coronavirus diagnostic products, Fulgent Genetics (NASDAQ:FLGT) grew by 280% in 2020, and its management increased its full-year revenue guidance by $100 million in November. Its revenue expanded by more than 880% in the third quarter compared to 2019, and the company is firmly profitable. Plus, its $2.74 million in debt barely holds a candle to its trailing revenue in excess of $135 million. There's a lot for investors to like, to say the least.

There's more to the company than its coronavirus tests, however. It also offers genetic testing for a handful of hereditary cancers and other disorders. Further investment in expanding its market penetration with these products will help to keep the company's momentum next year and beyond. In the meantime, investors can look forward to the next quarterly earnings report, which almost certainly will have even more good news.

See original here:
These Were the 5 Top Genetics Stocks of 2020 - Motley Fool

Genetic Testing Services Market Overview:

Research report on the Genetic Testing Services market by Market Growth Insight covers deep analysis on key factors that help business players to plan their future actions accordingly. The Genetic Testing Services market report discloses vital information like market share, market size, and growth rate for the forecast period 2020- 2026. The report on Genetic Testing Services market also comprises information on the stringent government regulations in key regions, such as import and export status, product price, FDA approvals, consumer buying behavior, Further the Genetic Testing Services market is categorized on the basis of product, end use industries, and region.

Global Genetic Testing Services market is anticipated to reach USD XX billion by the end of 2020 along with CAGR of XX % over the forecast period 2020 2026.

Get Sample Copy (Including FULL TOC, Graphs and Tables) of this report @: https://www.marketgrowthinsight.com/sample/177764

Global Genetic Testing Services Market segments by Manufacturers:

Major Type of Genetic Testing Services Market Covered:

Application Segments Covered in Market

COVID-19 Analysis:

The disturbances caused by the novel Coronavirus is being witnessed by all the industries. Some of the major interruptions include cancellations of flights, disruptions in logistics, reduced demand and production, delayed supply of essential raw materials, rejected delivery of key components to the end use industries, increased panic among consumers, higher pressure on healthcare industry, and more. Several key regions are also experiencing prolonged lockdown due to speedy spread of the virus. Also businesses are witnessing many disturbances including delayed product launches, interruptions in innovations, and less working population in work areas. Nevertheless, researchers have mentioned about the strategies adopted by key vendors during pandemic and other planning and activities to alleviate the Genetic Testing Services market post-pandemic.

The Genetic Testing Services market discusses details on the leading product type. The Genetic Testing Services report also offers deep analysis on the potential product segment that is expected to lead in the forthcoming years. Also, information on other product segments is given in the Genetic Testing Services market report to help the competitors and customers get a clear picture of the market and details on the upcoming product, respectively.

The Genetic Testing Services market research report provides detailed information on the dominating end use industry that demand the product on a larger scale along with details on the potential end use industry that is anticipated to surpass the demand of the current prominent end use Genetic Testing Services industry.

Get Special Discount @ https://www.marketgrowthinsight.com/discount/177764

Regional Analysis of Genetic Testing Services Market Research Report:

The Genetic Testing Services market report is segmented as North America, Latin America, Asia Pacific, Europe, and Middle East and Africa. These regions are described well and elaborated with demographic insights and potential lucrative regions for the business owners to tap and expand their business geographically. This will also help the producers to understand the demands of consumers in a better way and manufacture goods accordingly.

In addition, competitive analysis is also precisely mentioned in the Genetic Testing Services report to help the new entrants plan effective establishment policies and approaches and gain prominent position among competitors. The commonly adopted growth strategies are also included in the Genetic Testing Services market report. Also, the existing players can plan effective approaches for future and gain leading ranking.

Some of the queries answered in the report comprise:

Make an Enquiry for purchasing this Report @ https://www.marketgrowthinsight.com/inquiry/177764

About Market Growth Insight

We are striving to provide the best customer friendly services and appropriate business information to accomplish your ideas. The skilled and experienced professionals at Market Growth Insight are our strength and the position we have earned in the industry. This is what makes us to offer our clients to excel and enable competitive prices while retaining the best services. We are incorporated with a vision to provide the complete solution required for successful business execution. Our only motto is to resolve customer fulfillment completely. We provide the quality and customized research reports from the best publishers in the world.

Contact Us:

Direct Line:+1 3477675477 (US)Email:[emailprotected]Web:https://www.marketgrowthinsight.com

Read more here:
Genetic Testing Services Market Research Report is Projected to Witness Considerable Growth by 2026 - Farming Sector

Predictive Genetic Testing and Consumer/Wellness Genomics Market: Snapshot

Genetic testing comprises examination of ones DNA. The term DNA refers to the chemical database that is responsible for conveying the instructions for functions that need to be performed by the body. Genetic testing is capable of revealing changes or mutations in the genes of living beings, which might result in any kind of disease or illness in the body.

Get Exclusive PDF Sample Copy Of This Report:https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1274

Predictive genetic testingrefers to the utilization of genetic testing methods in an asymptomatic individual to make a prediction about risk of contacting particular disease in future. These tests are regarded as representation of emerging class of medical tests, which differ in fundamental ways from the usual diagnostic tests.

The global predictive genetic testing and consumer/wellness genomics marketis likely to gather momentum owing to the benefits offered by predictive genetic testing.

The benefits of predictive genetic testing are

The global predictive genetic testing and consumer/wellness genomics marketis influenced by reducing cost of genetic sequencing and technological advancement in the field of genetics. North America is expected to emerge as a prominent region for the global predictive genetic testing and consumer/wellness genomics market in years to come due to high adoption rates of latest technologies in all fields.

Over centauries human DNA has undergone tremendous alteration due to evolutionary and lifestyle changes. They have led to both, advantages and disadvantages over the years. Some have given the mankind a deserving edge over other creatures while the others have led to disorders and diseases. Predictive genetic testing and consumer/wellness genomics market thrives on the growing demand for understanding the lineage of a certain gene pool to identify disorders that could manifest in the later or early stage of a human life. The surging demand for understanding the family history or studying the nature of certain diseases has given the global market for predictive genetic testing and consumer/wellness genomics market adequate fodder for growth in the past few years.

This new class of medical tests are aimed at reducing the risk of morbidity and mortality amongst consumers. The thorough surveillance and screening of a certain gene pool can allow an individual to avoid conditions that disrupt normal existence through preventive measures. The clinical utility of these tests remains unassessed. Therefore, increasing research and development by pharmaceutical companies to develop new drugs by understanding diseases and disorders is expected to favor market growth.

Unlike conventional diagnostic testing, predictive genetic testing identifies the risk associated with potential conditions. In certain cases it is also capable of stating when the disease may appear and the how severe will it be. Thus, this form of testing is expected to allow consumers to take up wellness measurements well in time to lead a life of normalcy, characterized by good health.

Buy This Report @https://www.tmrresearch.com/checkout?rep_id=1274<ype=S

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Overview

Predictive genetic testing are used to identify gene mutations pertaining to the disorders that surface at a considerably later stage in life after birth. These tests are particularly beneficial for people from a family with a history of genetic disorder, although they themselves show no symptoms of the disorder at the time of testing. Genetic testing promises to revolutionize the healthcare sector, providing crucial diagnostic details related to diverse verticals such as heart disease, autism, and cancer. As the healthcare sector touches new peaks, the global predictive genetic testing and consumer/wellness genomics market is projected to expand at a healthy growth rate during the forecast period of 2017 to 2025.

This report on the global market for predictive genetic testing and consumer/wellness genomics analyzes all the important factors that may influence the demand in the near future and forecasts the condition of the market until 2025. It has been created using proven research methodologies such as SWOT analysis and Porters five forces. One of the key aspect of the report is the section on company profiles, wherein several leading players have been estimated for their market share and analyzed for their geographical presence, product portfolio, and recent strategic developments such as mergers, acquisitions, and collaborations.

The global predictive genetic testing and consumer/wellness genomics market, on the basis of test type, can be segmented into predictive testing, consumer genomics, and wellness genetics. The segment of predictive testing can be sub-segmented into genetic susceptibility test, predictive diagnostics, and population screening programs, whereas the segment of wellness genetics can be further divided into nutria genetics, skin and metabolism genetics, and others.

By application, the market can be segmented into breast and ovarian cancer screening, cardiovascular screening, diabetic screening and monitoring, colon cancer screening, Parkinsons or Alzheimers disease, urologic screening or prostate cancer screening, orthopedic and musculoskeletal screening, and other cancer screening. Geographically, the report studies the opportunities available in regions such as Asia Pacific, Europe, North America, and the Middle East and Africa.

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Trends and Opportunities

Increasing number of novel partnership models, rapidly decreasing cost of genetic sequencing, and introduction of fragmented point-solutions across the genomics value chain as well as technological advancements in cloud computing and data integration are some of the key factors driving the market. On the other hand, the absence of well-defined regulatory framework, low adoption rate, and ethical concerns regarding the implementation, are expected to hinder the growth rate during the forecast period. Each of these factors have been analyzed in the report and their respective impacts have been anticipated.

Currently, the segment of predictive genetic cardiovascular screening accounts for the maximum demand, and increased investments in the field is expected to maintain it as most lucrative segment. On the other hand, more than 70 companies are currently engaged in nutrigenomics, which is expected to further expand the market.

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Regional Outlook

Owing to robust healthcare infrastructure, prevalence of cardiovascular diseases, and high adoptability rate of new technology makes North America the most lucrative region, with most of the demand coming from the country of the U.S. and Canada. Several U.S. companies hold patents, which further extends the outreach of the market in the region of North America.

Companies mentioned in the research report

23andMe, Inc, BGI, Genesis Genetics, Illumina, Inc, Myriad Genetics, Inc, Pathway Genomics, Color Genomics Inc., and ARUP Laboratories are some of the key companies currently operating in global predictive genetic testing and consumer/wellness genomics market. Various forms of strategic partnerships with operating company and smaller vendors with novel ideas helps these leading players maintain their position in the market.

To know more about the table of contents, you can click @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1274

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to busi-ness entities keen on succeeding in todays supercharged economic climate. Armed with an experi-enced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

See more here:
Predictive Genetic Testing and Consumer/Wellness Genomics Market Rear Excessive Growth During 2017 to 2025 - Farming Sector

The market research report contains important details regarding the Predictive Genetic Testing market value based on market dynamics and various growth factors. It examines various key aspects of the market, including the latest technological innovations in the industry, current trends, and development opportunities. In this report, we analyze the Predictive Genetic Testing industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions at the same time, we classify different Predictive Genetic Testing based on their definitions. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What is more, the Predictive Genetic Testing industry development trends and marketing channels are analyzed. In addition, this report introduces market competition situation among the vendors and company profile, and besides market price analysis and value chain features are covered in this report.

Get A Sample Copy of Research Report at: https://www.adroitmarketresearch.com/contacts/request-sample/1276?utm_source=Bhagyashri

The report represents the exact condition of the current market which includes Business Opportunity, Innovations, Upcoming-Trends, Growth-Analysis, Demand-Insight, Top-Manufacturers for the forecast year 2020 to 2025. Our board of exchange experts has immense enormous endeavors in doing this gathering activity so as to deliver important and dependable essential and optional information with respect to the Predictive Genetic Testing market.

Essential Key Players involved in Global Predictive Genetic Testing Market are:

Agilent, Technologies, Inc., BGI Genomics, F.Hoffman-La Roche Ltd., Genes In Life., Invitae Corporation, Illumina, Inc., 23andMe, Myriad Genetics, Inc., Pathway Genomics and Thermo Fisher Scientific, Inc.

Browse the complete report Along with TOC @ https://www.adroitmarketresearch.com/industry-reports/predictive-genetic-testing-market?utm_source=Bhagyashri

The detailed information in this reports will help the companies to make informed Marketing strategies. Moreover, ultimate goal of Market research is to analyze how the Markets target group will obtain a product or service. Market research report is predominantly prepared following certain methodology and guidelines for collecting, organizing and analyzing data. It also delivers the business models, strategies, growth, innovations and every information about key manufacturers that will enable in making business estimates. In addition, every Market has a set of manufacturers, vendors and consumers that define the Market as well as their every moves and achievements becomes a subject of studying for Market analysts.

Global Predictive Genetic Testing Market: Understanding ScopeBearing in mind the need for reader convenience, seasoned researchers of our in-house teams have identified 2020 as the base year and pinned the years between 2020-25 as the overall growth span. This is likely to give a glimpse of both the past and current happenings that systematically influence forecast estimation. Additionally, the report also takes into account the CAGR estimation and percentage that is likely to remain optimistic through the forecast span.

Market SegmentationMarket by Types

by Types (Predispositional Testing and Presymptomatic Testing), by Demographics (<35, 35 ? 64 and 65+)

An Overview of Regional Developments: Global Predictive Genetic Testing Market The overall spectrum of the global Predictive Genetic Testing market is broadly diversified into North and South America, Europe, APAC, and MEA. The report gauges into vital details such as manufacturer performance and overall growth activities across potent growth hubs. A close review of the overall growth rate during both past and current timelines have been meticulously highlighted to encourage thoughtful business decisions in global Predictive Genetic Testing market A clear reference of the overall revenue generation, sales performance as well as growth rate synopsis have been thoroughly structured in this versatile research report on global Predictive Genetic Testing market. Further in the report, readers are presented with substantia, cues on vendor landscape, frontline players and their company profiles and performance analysis have all been optimally highlighted in this report to encourage adequate reader discretion.

Chief Reasons for Report Investment The report lends a highly time specific, forward-looking scenario of the global Predictive Genetic Testing market The report offers a highly systematic overview of DROT analysis, involving detailed explanation of key market drivers, constraints, risks, and growth opportunities. The report also includes a complete five-year forecast assessment that allow manufacturers well gauge into futuristic growth probabilities The report is a handy-ready-to-refer guide to emphasize workability and growth potential of each of the segments, allowing readers to comprehend the investment potential of each segment. The report is an indispensable guide to understand and carry out a pin-point analysis of the fast-changing competitive landscape to encourage well informed business decisions favoring sustainability and long-term revenue generation potential in global Predictive Genetic Testing market.

3-Pointer Evaluation of COVID-19 Impact The report renders a thoroughly evaluated market outlook of the world perspective and the overall economic overview Stark differences and alterations in demand and supply chains have been highlighted A crisp pre and post COVID-19 developments and beyond have also been tagged in this corporate report on global Predictive Genetic Testing market.

Considering the existing market scenario, our seasoned researchers and expert panelists have relied heavily on intense research practices to offer an extensive range of market predictions for an exhaustive clientele reference of dynamics, dominating global growth outlook in Predictive Genetic Testing market. The unprecedented outrage of COVID-19 pandemic has affected adversely several businesses across industries. We aim to offer highly reliable and relevant action plan to offset the implications for further growth spurt in global Predictive Genetic Testing market. Customization remains crucial decision maker that always keeps us most preferred market intelligence provider for a burgeoning clientele.

Make an enquiry of this report: https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/1276?utm_source=Bhagyashri

About Us :

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code- Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan JohnsonAccount Manager Global3131 McKinney Ave Ste 600, Dallas,TX 75204, U.S.APhone No.: USA: +1 972-362 -8199 / +91 9665341414

View post:
Predictive Genetic Testing Market Size 2020, Global Trends, Industry Share, Growth Drivers, Business Opportunities and Demand Forecast to 2025 -...

New Jersey, United States,- The report, titled Preimplantation Genetic Testing Market Research Report is based on the extensive analysis of analysts and contains detailed information on the global market area. A detailed examination of the business landscape, as well as the essential parameters that shape the marketing matrix of the market, is included.

A thorough qualitative and quantitative study of the global market has been conducted in this report. The study takes into account various important aspects of the market by focusing on historical and forecast data. The report provides information on the SWOT analysis as well as Porters Five Forces Model and the PESTEL analysis.

The Preimplantation Genetic Testing Market research documentation provides details on drivers and restraints, regional growth opportunities, market size, as well as the spectrum of competition, prominent market candidates, and segment analysis.

The following Manufacturers are covered in this report:

The report aims to enumerate various data and updates related to the World Market while developing various growth opportunities that are believed to support the market growth at a significant rate during the forecast period. The report provides an insightful overview of the Preimplantation Genetic Testing market along with a well-summarized market definition and detailed industry scenario.

A comprehensive summary revolves around market dynamics. The segment encompasses insights into the drivers driving the growth of the Preimplantation Genetic Testing market, restrictive parameters, existing growth opportunities in the industry, and the numerous trends that define the global marketplace. The report also includes data on pricing models and a value chain analysis. The expected growth of the market during the analysis period based on the estimates and historical figures has also been factored into the study.

The Preimplantation Genetic Testing market report provides details of the expected CAGR recorded by the industry during the investigation period. Additionally, the report includes a number of technological advances and innovations that will boost the industrys prospects over the estimated period.

The report further studies the segmentation of the market based on product types offered in the market and their end-use/applications.

1.Label-Free Detection Market, By Technology:

1.Label-Free Detection Market, By Products:

3.Label-Free Detection Market, By End User:

4.Label-Free Detection Market, By Application:

Geographic Segmentation

The report offers an exhaustive assessment of different region-wise and country-wise Preimplantation Genetic Testing markets such as the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

North America, Europe, Asia-Pacific, Latin America, The Middle East and Africa

What are the main takeaways from this report?

A comprehensive price analysis was carried out in relation to product area, range of applications and regional landscape A comprehensive round up of the key market players and leading companies operating in the Preimplantation Genetic Testing Market to understand the competitive perspective of the global marketplace Important information on the regulatory scenario that defines the market, as well as the inflow of investments from majority stakeholders in the world market An in-depth assessment of the various trends that are fueling overall market growth and their impact on global market projection and dynamics A descriptive guide that identifies the key aspects along with the many growth opportunities in the Preimplantation Genetic Testing market A detailed documentation of a wide variety of ongoing issues in the world market that will encourage important developments

Some Points from Table of Content

1. Study coverage2. Summary3. Preimplantation Genetic Testing Market Size by Manufacturer4. Production by region5. Consumption by region6.Preimplantation Genetic Testing Market Size by Type7. Preimplantation Genetic Testing Market size according to application8. Manufacturer profiles9. Production forecasts10. Consumption forecasts11. Analysis of customers upstream, industrial chain and downstream12. Opportunities and challenges, threats and influencing factors13. Main results14. Appendix

Verified Market Intelligence is a BI enabled database service with forecasted trends and accurate market insights on over 20,000+ tracked markets helping organizations globally with their market research needs. VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment and Key players for emerging and niche markets.

About Us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll-Free: +1 (800)-7821768

Email: [emailprotected]

View post:
Preimplantation Genetic Testing Market Size, Share, Growth Trends, Revenue, Top Companies, Regional Outlook, and Forecast, 2020-2027 - LionLowdown

A waning 2020 delivered a final kick on the way out Thursday with the county health department announcing 62 additional COVID-19 deaths, a new single-day record arriving on New Years Eve.

And there was an extra reason for concern. The county public health lab, working with local researchers, confirmed three more cases of the United Kingdom coronavirus strain Thursday, bringing the total to four, including the initial case involving a man in his 30s announced Wednesday.

Officials said none of the four are related and had no contact with each other before testing positive.

The three additional cases confirmed Thursday were all men. Case investigators have interviewed two of the three who reported no recent travel outside the country. Two of the three new cases were in their 40s and the third was in his 50s. The third case for whom travel information was not available had not yet been interviewed.

They live in La Mesa, Otay Mesa, Mission Beach and the Rancho Bernardo-Carmel Mountain area.

The county public health lab was still awaiting the results of genetic testing to confirm whether a close contact of Wednesdays first UK strain subject, who was said to have been experiencing symptoms of coronavirus infection, also has the UK strain.

Dr. Eric McDonald, medical director of the countys epidemiology department, said Thursday evening that the subject, a woman also in her 30s who is the spouse of Wednesdays UK case, has been admitted to a hospital after testing positive for coronavirus. Genetic testing being performed by Scripps Research will be necessary to confirm that the UK strain was involved, but that seems very likely at this point.

I would be shocked if it doesnt come back with whole-genome sequencing that confirms it, McDonald said.

He said the three additional UK cases confirmed through genetic testing Thursday were actually tested between Dec. 20 and Dec. 22. Helix, a local company that the county contracts with for testing, looked through its records after the first case appeared and discovered the results as having the telltale s drop signature that marked Wednesdays case.

Having cases from different parts of the county that did not know each other, he said, shows that this strain, which is thought to spread more easily than other variants, has been among us for some time.

This didnt just spread to that many different parts of the county among people who dont know each other in the past two weeks, McDonald said. The dispersal of these cases geographically tells you that it has probably been in the county for a longer period of time.

With 99 deaths announced in just the past two days, December is by far the deadliest month of the pandemic. According to county records, 488 deaths have been recorded in December, more than twice the previous monthly record of 197 tallied in July.

The most recent deaths announced Thursday range in age from 45 to 100 with three in their 40s. As is always the case, the deaths announced on any given day did not all occur the day before the announcement. It can take days or weeks for death certificates and causes of death to be finalized before they are reported to the public.

Taking the latest group into account, records show that a total of 28 deaths occurred on Dec. 22, tying Dec. 18 for the deadliest day of the pandemic.

McDonald said he reviews each and every death certificate before the county releases new numbers. Seeing so many in December, he said, has been particularly harrowing.

Every one of those is a person and has a family, McDonald said. What this means is that there are more and more San Diego families that are coming to grips with the fact that this is a real and deadly pandemic.

Deaths are what epidemiologists call a lagging indicator, generally occurring weeks or months after infections take hold. As such, a spike in deaths does not, in and of itself, say all that much about how a pathogen such as the novel coronavirus is spreading in a community. The number of new positive cases coming in daily provides a more immediate sense of the current pace of infection.

The final COVID-19 report of 2020 lists 3,083 new cases, once again jumping over the 3,000 mark after three straight days below that mark. The result could signal the arrival of a new wave of cases connected to Christmas celebrations, given that the average incubation period for the virus the amount of time spent in the body before symptoms generally begin to appear is about 6 days, according to the U.S. Centers for Disease Control and Prevention.

Pressure continues to mount on local hospitals with 1,580 total COVID-19 patients in beds across the county Wednesday. COVID-positive patients occupied 35 percent of the 4,504 total beds in use. Intensive care admissions held steady at 621 with 386 having a COVID-19 diagnosis and 235 without.

Read this article:
San Diego County ends 2020 with largest single-day COVID-19 death total of the year - The San Diego Union-Tribune

The Direct Genetic Testing for Consumer Market report was conducted across a variety of businesses in various regions to produce a worthy report that represents the proficient analysis of the industry. The report provides a competitive study of leading market players, market growth, consumption (sales) volume, key drivers and limiting factors, future projections for the new-comer to plan their strategies for global Direct Genetic Testing for Consumer Market business. The report highlights key market expansions, industry and competitors challenges in gap analysis and new opportunities and key trends in the market. The report studies many aspects of the industry like the market size, market status, market trends and forecast from 2020 to 2026 time period.

Report Overview:

Report Ocean analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry. We will also include the impact of COVID-19 new strain found in UK.

Request Free Sample Report athttps://reportocean.com/industry-verticals/sample-request?report_id=QY13750

The global Direct Genetic Testing for Consumer Market research study is to define market sizes of various segments & countries by past years and to forecast the values by next 5 years. The report is assembled to comprise each qualitative and quantitative elements of the industry facts including market share, market size (value and volume 2015-19, and forecast to 2026) which admire each country concerned in the competitive examination. Further, the study additionally caters the in-depth statistics about the crucial elements which includes drivers & restraining factors that defines future growth outlook of the market.

Competitive Landscape:

Competitive landscape of a market explains the competition in the Direct Genetic Testing for Consumer Market taking into consideration price, revenue, sales, and market share by company, market concentration rate, competitive situations, trends, and market shares of top companies. Strategies incorporated by key players of the market such as investment strategies, marketing strategies, and product development plans are also further included in the report. The research integrates data regarding the producers product range, top product applications, and product specifications.

The major players in the Direct Genetic Testing for Consumer Market are:

Market Segmentation:

The segmentation is used to decide the target market into smaller sections or segments like product type, application, and geographical regions to optimize marketing strategies, advertising technique and global as well as regional sales efforts of Direct Genetic Testing for Consumer Market.

Regional and Country-level Analysis

The market size information is provided by regions (countries) in the Direct Genetic Testing for Consumer Market report.

The key regions covered in the Direct Genetic Testing for Consumer Market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.

Tools Used for Analysis in This Report:

The Direct Genetic Testing for Consumer Market report has used analytical tools to include accurate research and evaluation data on key industry players and market coverage. Report Ocean experts have analyzed the growth of leading companies operating in the marketplace using analytics tools such as Porters five power analysis, SWOT analysis, feasibility study and ROI analysis.

Inquire or Share Your Questions If Any before Purchasing This Report:https://reportocean.com/industry-verticals/sample-request?report_id=QY13750

Table of content

1 Direct Genetic Testing for Consumer Market Overview

1.1 Product Overview and Scope of Direct Genetic Testing for Consumer

1.2 Direct Genetic Testing for Consumer Segment by Type

1.2.1 Global Direct Genetic Testing for Consumer Production Growth Rate Comparison by Type 2020 VS 2026

1.2.2 Diagnostic Screening

1.2.3 Prenatal, Newborn Screening, and Pre-Implantation Diagnosis

1.2.4 Relationship Testing

1.3 Direct Genetic Testing for Consumer Segment by Application

1.3.1 Direct Genetic Testing for Consumer Consumption Comparison by Application: 2020 VS 2026

1.3.2 Online

1.3.3 Offline

1.4 Global Direct Genetic Testing for Consumer Market by Region

1.4.1 Global Direct Genetic Testing for Consumer Market Size Estimates and Forecasts by Region: 2020 VS 2026

1.4.2 North America Estimates and Forecasts (2015-2026)

1.4.3 Europe Estimates and Forecasts (2015-2026)

1.4.4 China Estimates and Forecasts (2015-2026)

1.4.5 Japan Estimates and Forecasts (2015-2026)

1.5 Global Direct Genetic Testing for Consumer Growth Prospects

1.5.1 Global Direct Genetic Testing for Consumer Revenue Estimates and Forecasts (2015-2026)

1.5.2 Global Direct Genetic Testing for Consumer Production Capacity Estimates and Forecasts (2015-2026)

1.5.3 Global Direct Genetic Testing for Consumer Production Estimates and Forecasts (2015-2026)

1.6 Direct Genetic Testing for Consumer Industry

1.7 Direct Genetic Testing for Consumer Market Trends

2 Market Competition by Manufacturers

2.1 Global Direct Genetic Testing for Consumer Production Capacity Market Share by Manufacturers (2015-2020)

2.2 Global Direct Genetic Testing for Consumer Revenue Share by Manufacturers (2015-2020)

2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.4 Global Direct Genetic Testing for Consumer Average Price by Manufacturers (2015-2020)

2.5 Manufacturers Direct Genetic Testing for Consumer Production Sites, Area Served, Product Types

2.6 Direct Genetic Testing for Consumer Market Competitive Situation and Trends

2.6.1 Direct Genetic Testing for Consumer Market Concentration Rate

2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue

2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

3.1 Global Production Capacity of Direct Genetic Testing for Consumer Market Share by Regions (2015-2020)

3.2 Global Direct Genetic Testing for Consumer Revenue Market Share by Regions (2015-2020)

3.3 Global Direct Genetic Testing for Consumer Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.4 North America Direct Genetic Testing for Consumer Production

3.4.1 North America Direct Genetic Testing for Consumer Production Growth Rate (2015-2020)

3.4.2 North America Direct Genetic Testing for Consumer Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.5 Europe Direct Genetic Testing for Consumer Production

3.5.1 Europe Direct Genetic Testing for Consumer Production Growth Rate (2015-2020)

3.5.2 Europe Direct Genetic Testing for Consumer Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.6 China Direct Genetic Testing for Consumer Production

3.6.1 China Direct Genetic Testing for Consumer Production Growth Rate (2015-2020)

3.6.2 China Direct Genetic Testing for Consumer Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.7 Japan Direct Genetic Testing for Consumer Production

3.7.1 Japan Direct Genetic Testing for Consumer Production Growth Rate (2015-2020)

3.7.2 Japan Direct Genetic Testing for Consumer Production Capacity, Revenue, Price and Gross Margin (2015-2020)

4 Global Direct Genetic Testing for Consumer Consumption by Regions

4.1 Global Direct Genetic Testing for Consumer Consumption by Regions

4.1.1 Global Direct Genetic Testing for Consumer Consumption by Region

4.1.2 Global Direct Genetic Testing for Consumer Consumption Market Share by Region

4.2 North America

4.2.1 North America Direct Genetic Testing for Consumer Consumption by Countries

4.2.2 U.S.

4.2.3 Canada

4.3 Europe

4.3.1 Europe Direct Genetic Testing for Consumer Consumption by Countries

4.3.2 Germany

4.3.3 France

4.3.4 U.K.

4.3.5 Italy

4.3.6 Russia

4.4 Asia Pacific

4.4.1 Asia Pacific Direct Genetic Testing for Consumer Consumption by Region

4.4.2 China

4.4.3 Japan

4.4.4 South Korea

4.4.5 Taiwan

4.4.6 Southeast Asia

4.4.7 India

4.4.8 Australia

4.5 Latin America

4.5.1 Latin America Direct Genetic Testing for Consumer Consumption by Countries

4.5.2 Mexico

4.5.3 Brazil

5 Direct Genetic Testing for Consumer Production, Revenue, Price Trend by Type

5.1 Global Direct Genetic Testing for Consumer Production Market Share by Type (2015-2020)

5.2 Global Direct Genetic Testing for Consumer Revenue Market Share by Type (2015-2020)

5.3 Global Direct Genetic Testing for Consumer Price by Type (2015-2020)

See the original post here:
Direct Genetic Testing for Consumer Market is expected to show impressive growth rate between 2020 to 2026 - LionLowdown

In her new book, Twelve Paintings, writerTal Sterngast explores Berlins Gemldegalerie, which is known for an exceptional collection of European paintings. She lands on twelve paintings from the collection and investigates the story behind them through important questions of today. In this chapter, called The Creativity of Women, Sterngast looks at the legacy of prominent French portraitist lisabeth Vige Le Brun, one of the few women artists in the Berlin state collection, asking what paradoxes exist within art that is made by women.

Born in 1755 in Paris to a painter and a hairdresser, Elisabeth Vige-Lebrun achieved success in France and Europe against the norms of the time during one of the most turbulent periods in European history. Her father, who recognized the daughters talent and passion early on, died when she was 12. In her feminist essay Why Have There Been No Great Women Artists? from 1971, the art historian Linda Nochlin noted that, denied access to workshops, academies, or universities, almost all women artists known to us before the 20th century had a father in the profession.

From around 2,800 paintings in Berlins Gemldegalerie collection made north and south of the Alps between the 13th and the 18th century, 15 were painted by nine women. With the exception of Italian Renaissance painter Sofonisba Anguissola, all of them came from the northern countries and lived around the 18th century. Vige-Lebrun learned to paint by looking at and copying art in Paris, and began working as a portraitist in her youth, supporting her widowed mother and brother for a time. Soon after encountering Marie Antoinette, she became her court painter, the first woman to attain this rank. Admitted to the Acadmie Royale de Peinture et de Sculpture (Royal Academy of Painting and Sculpture) at age 28, she became one of only four women members and one of the leading portraitists of the ancien rgime.

Neither boy nor girl, neither adult nor child; not completely human, animal, or divine, the prince holds a laurel wreath demonstratively in the air. It is an opening waiting to be breached, whereas the phallic quiver of arrows laying partially concealed at his feet is a latent weapon, a possible complement to entering the ring. Echoing this potential intercourse or coupling, the princes winged figure hybridizes classic mythology with Jewish-Christian motifs. Cupid-Erosthe mischievous god of love equipped here with arrows but no bow, a reminder of the ancient knot that ties love with a woundis combined with a Judeo-Christian angel: a cherub or seraph. The two cherubim in rabbinic literature are described as human-like entities with wings, placed on the opposite ends of the Ark of the Covenant in the inner sanctum of the temple, containing the two stone tablets of the Ten Commandments. Representing a threshold between profane and sacred, between the given world and the one beyond, they guard the law. Higher in ancient Judaism and Christianitys hierarchy of angels, the seraphim announces the sacred name of God and its distinction from its creations. These winged creatures separate and connect human and divine, man, and God.

lisabeth Vige-Lebruns Prince Heinrich Lubomirski as the Geniusof Fame (178788). Acquired in 1874 from the Gallery. Fr. Heim, Paris. Photo: Jrg P. Anders.

In Western iconography, the distinction between seraph and cherub echoes the broad division between faith and reason; cherubs, the former; seraphs, the latter. Cupid as cherub thus takes the pagan idea of a demigod and superimposes it on the Catholic notion of an angel of the sort linked with encouragement to faith as opposed to reason; the latter would be the seraphs concern. The hybridization of Cupid and cherub may therefore point to an aspiration of synthesizing desire and faith. Could it be that the little princes androgyny, with the ambiguities or thresholds it captures, reverberates the zeitgeist of drastic transformations? The revolutionary program of the period was marked byor part ofa secularization of the divine, the exchange of the metaphysics of religion with revolutionary ideas and the loss of the sacred. What exactly was Vige-Lebrun idolizing in her Lubomirski portrait?

The genius of love, disguised in a portrait of a boy, not only evokes a sense of immanentization (as Greco-Roman gods often do, anthropomorphized and restlessly intervening in human affairs) but also implies a certain diffusion or inversion within the active/passive oppositions of man and woman, artist and model, subject, and object. As a portraitist at a time when women were denied apprenticeships and forbidden from drawing nudes, Vige-Lebrun was aware of the power relations inherent to the gaze. In her memoir, she admits to flirting with her male sitters: As soon as I observed any intention on their part of making sheeps eyes at me, I would paint them looking in another direction than mine, and then, at the least movement of the pupilla, would say, I am doing the eyes now.

Even when women were already officially permitted at the School of Fine Arts in Paris (and in other European art schools) much later at the end of the 19th century, they were still not allowed to copy the naked body. That undressed, to-be-painted body was not only standing for painting itself and the speculation of a passivity/activity dichotomy, but also to the question of truth, the naked truth. That was the time when Friedrich Nietzsche stressed how much the questions of art, style, and truth can not be dissociated from the question of the woman. An answer to the question what is woman cannot be found in any of the familiar modes of concept or knowledge, he noted. Yet it is impossible to resist looking for her. Men, asserts French philosopher Genevive Fraisse, didnt want women involved in the question of beauty, because it is married to the question of truth. It belonged to men. Copying the naked body, therefore, is also about gaining access to the truth.

Is there a difference between feminine and masculine creativity? And if there is one, how is it to be argued? Nochlins essay laid ground for a feminist methodology in art history, claiming that this question was the wrong one to begin with. Acknowledging that there were no women equivalents for Michelangelo or Rembrandt, Czanne, Picasso, or Matisse, or even for de Kooning or Warhol, she made the point that the fault lay not in womens genetics, but rather in institutions and education. As well as that art is not a means of pure self-expression but rather something that involves a self-consistent language of form, given conventions, which must be learned through teaching or individual work. Women were consistently and systematically denied access to both. In addition, she criticized the myth of the innate genius as an atemporal and mysterious power, embedded in the person of the great artist, a godlike figure.

While Nochlin and much of feminist art history after her rightly stressed the importance of the institutional over the individual, the question that is asked too little today is not whether women can make art or not anymore, but if and how women can be creative without adopting masculine attributes, without being creative like a man. Does the fact that there is no female style in the works of great women artists from Artemisia Gentileschi to Agnes Martin mean that theres nothing in common among women artists? Can a woman artist define art anew in radicality like, for example, Diego Velazquez, Marcel Duchamp, or Andy Warhol, or is it a different game altogether? Can the creativity of women extricate itself from the metaphor, from being an image; one that belongs to the sphere of mere appearances and temptation, but also to nature and motherhood?

Agnes Martin Untitled I (1985). Courtesy of Phillips.

Between its two facetsthe monstrous imagination of an endless birth-giving, as opposed to a suffering of being as endurance, in absencewhat are the paradoxes within which art is made by women? Corresponding to the former is much of performance art by women since the 1970s, which relates to taboo aspects of bodies: menstrual blood, childbearing, excrement, internal organs; or, differently, art made by and after Louise Bourgeoiss surrealism, vividly feeding off trauma and lending unconscious visual tropes (stairs, spiders, cages) meaning that is both narrative and therapeutic. In correlation to the latter, one can think of Agnes Martins repetitive grids that achieve not what is seen, but what is known forever in the mind unfolding contemplative states of existence. Or Vija Celminss detailed drawings and paintings of starry skies, spider webs, or the ocean as surfaces of spiritual solitude and retinal allure.

If the domain of modern art and artifice is understood as a substitute for fecundity, an outcome of a creativity which is in its essence masculine, what art can be made in fertility? Asking this question might risk all that womens fight for equality has accomplished. However, not asking it might be denying the potentialities of art made by women as something that can best be described as total otherness in this given, androcentric world.

Tal Sterngaststudied photography and film in Jerusalem, London, and Berlin. She has published numerous essays and articles about contemporary art and film in international newspapers and art magazines. She has organized several exhibitions. Her newbook, out now in English and in German with publisher Hatje Cantz, is based on the article series Alte Meister, published in the weekend supplement of die Tageszeitung from 2017 until 2019.

More here:
A Look at the Subversive Art of lisabeth Vige Le Brunand the One Gender-Bending Portrait That Has Kept Historians Guessing - artnet News

Categories: -The Daily Gazette, High School Sports, Sports

Its always been big news when a player from Section II makes a commitment to join a Division I womens basketball program.

That happened seven times in recent months, a mass splurge that created a big story all of its own.

I remember when two or three was a good year, said former girls basketball coach Fran Pugliese, who began a 20-year stint at Draper and Columbia high schools back in 1977. Seven is amazing. Girls are playing so much now.

They are, and so many more will be joining in to compete, grow and be evaluated in places in and around the Capital Region that werent available not too long ago.

There were two AAU teams in this area when I was playing, said 1996 Burnt Hills-Ballston Lake graduate and current Niskayuna coach Sarah Neely. If you were lucky enough to make it.

Saratoga Springs coach and former Union College basketball standout Robin Chudy didnt even have that.

I played on a boys team that my dad coached, the 1988 Columbia graduate said. Back then, it wasnt huge.

The expansion of AAU programs and club teams in the area, and more recently organizations such as the Empire State Takeover, have helped change that.

There are more good players because there is more basketball available, former Shenendehowa girls coach Ken Strube said.

Section II has never seen a senior class of Division I commits quite like this one in respect to its large number and record of achievement. The all-star cast features Meghan Huerter of Shenendehowa (Providence), Niskayunas Olivia Olsen (Providence), state champion Cambridge twins Lilly Phillips (UAlbany) and Sophie Phillips (Rhode Island), Antonia May of Amsterdam (UMBC), Valencia Fontenelle-Posson of Guilderland (Siena) and Maddisyn Mahoney of Shaker (Fairleigh Dickinson).

Whether those players get a chance to play this winter season remains in question with COVID-19 cases on the rise and the high risk sport of basketball on hold in New York. Their level of dedication and talent, however, is without question.

The Capital Region has consistently produced some of the strongest players in upstate New York, but this is a special class, Empire State Takeover founder and director Jeff Mlinar said. Theyve all put in a ridiculous amount of work to get where they are.

All of them have been through the travel ball route and participated in Empire State Takeover activities that include league play and college showcase events. Family genetics and a large dose of family support, Mlinar noted, played a part in those Division I scholarships, too.

It shows that there are a lot of hard workers in the area, Lilly Phillips said of Section IIs Division I-bound class. It shows that our age group really loves basketball.

I think we started young and had a passion for basketball to get where we are now, Fontenelle-Posson said.

Mlinar said more Division I talent from Section II is on the way.

More girls are going to the scholarship level, said Mlinar, who will be entering his seventh year working with upstate girls. We will have another solid class next year and another one in 2023. We are trending in the right direction and I think well continue to do that. Some classes will be bigger than others.

Rhaymi Porter of Scotia, who will play at Division I Canisius after her 2021 graduation from Wilbraham & Monson Academy in Massachusetts, is another product of the Empire State Takeover program and the travel ball circuit.

There are more opportunities for girls to be in the gym, and develop and be seen, Mlinar said. A big point is they are getting the opportunity to do it at a younger age.

This class has been blessed to have the opportunities weve had, said Fontenelle-Posson, who joined the City Rocks AAU program when she was in third grade. Forty or 50 years ago, they didnt have that.

Shenendehowa was one of Section IIs first schools to reap the rewards of a strong youth program in terms of wins and championships on the court, and Divison I college scholarships to the player that made it happen, some of the earliest being 1988 graduate Wendy Czelusniak (New Mexico State), and 1990 twin graduates Laura and Debbie Barnes (Richmond).

Several more Division I players followed during the Strube era including Jen Scanlon (1992, Duke), who, like Debbie Barnes, earned the New York Miss Basketball award during her senior year. State career scoring leader Caryn Schoff of St. Johnsville (1995, Syracuse) and Carolyn Gottstein of Albany (2000, Boston College) would later garner that award, as well.

We had a ridiculous youth feeder program, said Strube, who won four state titles and 10 Section II championships in his coaching run at Shenendehowa from 1979-2012. The cool thing was the dads didnt just focus on their daughters. They developed the whole program, and I got the credit.

When I started out, they didnt start until high school, Pugliese said of his early groups at Draper. Theyre playing in third and fourth grade now.

I just think if you look at the 80s and 90s, girls sports started to evolve, Neely said. There are so many opportunities for female athletes in so many sports.

In more recent years, single-sport specialization has become more common among female athletes, weight rooms have became more available and personal trainers and coaches have became more prevalent.

Everything plays a role, Mlinar said.

Increased exposure of different kinds has also aided both players and college coaches in the recruiting process.

I remember when [former Daily Gazette sports editor] Butch Walker asked me if I wanted to cover a Bishop Gibbons girls basketball game. We had never done that before, said Bill Buell, a Gazette sportswriter from 1978 through 2002. The rest is history. A few years later, we put out our first Gazette All-Area girls basketball team.

Buell covered that initial girls game during the 1983-84 season, three years after the first NCAA Division I womens basketball tournament was staged, and a decade after Ann Meyers became the first female basketball player in the United States to get a four-year athletic scholarship from UCLA.

We always had a few good players, Buell said of his early years with the newspaper. The mindset was different then. Most girls didnt think about getting Division I scholarships.

Buell said star players such as Shawn Shafer, who went from Bishop Gibbons to Siena in 1986, Tanya Hansen, who went from Albany to Rutgers in 1988, and Anita Kaplan, who went from Bethlehem to Stanford in 1991, helped change that thought process.

Kaplan was in the national spotlight her freshman season when she played a role in Stanfords NCAA Division I championship. (That team, of course, was coached by Schenectady County native and all-time womens college basketball wins leader Tara VanDerveer, who struggled to find girls teams to play for in her youth.)

Once those girls started getting some publicity, others thought, We can do that, too,' Buell said. This avenue is open to me.'

Chudy saw youngsters flock to 2020 graduate Dolly Cairns, Saratoga Springs career points leader who is playing at Rhode Island, and 2019 grad Kerry Flaherty, who is competing at Holy Cross.

The neat part is watching the younger kids who want to emulate them, said Robin Chudy, whose team includes her daughter, sophomore Natasha Chudy one of Section IIs rising stars.

Fontenelle-Posson knows younger eyes are on her, as her own were on 2018 Niskayuna graduate Olivia Owens, who is currently playing at Kentucky after spending time with the Maryland program.

I watched her for a long time and still keep tabs on how she is doing, Fontenelle-Posson said. Its a cycle. Now its my turn to try to set an example so the younger girls can see what can happen with hard work.

Read this article:
Big rewards for Section II girls as basketball avenues increase - The Daily Gazette

January

4 Winners of five Costa category awards announced.8 The Father released Florian Zeller directs an adaptation of his own play, starring Anthony Hopkins.11 TS Eliot prize for poetry.19 Centenary of the birth of Patricia Highsmith, queen of psychological suspense.22 Netflix adaptation of Aravind Adigas Booker winner The White Tiger.Release of film Chaos Walking, based on first book of Patrick Nesss eponymous trilogy.26 Costa awards ceremony, with book of the year announced.

Fiction

Luster by Raven Leilani (Picador)In the years buzziest debut, a black American millennial tackles the difficulties of work, love, sex and being seen for who you really are.

The Living Sea of Waking Dreams by Richard Flanagan (Chatto & Windus)A family grapples with mortality while Australia burns, in a magical realist fable about extinction and Anthropocene despair from the Booker-winning author of The Narrow Road to the Deep North.

Memorial by Bryan Washington (Atlantic)His story collection Lot won last years Dylan Thomas prize; this deft debut novel explores the complications of family and a gay relationship on the rocks.

A Burning by Megha Majumdar (Scribner)Three lives entangle in contemporary India, in a debut about class and aspiration that has been a sensation in the US.

The Art of Falling by Danielle McLaughlin (John Murray)Debut novel about a woman rebuilding her marriage, from the celebrated Irish short story writer.

A River Called Time by Courttia Newland (Canongate)Ambitious speculative epic set in an alternate London where slavery and colonialism never happened.

People Like Her by Ellery Lloyd (Mantle)Smart, gobble-at-a-sitting thriller about life as a yummy mummy influencer and the dark side of Instagram.

Girl A by Abigail Dean (HarperCollins)Incendiary, beautifully written thriller debut about siblings living with the emotional legacy of childhood abuse in a House of Horrors.

The Stranger Times by CK McDonnell (Bantam)Pratchettesque romp set around a Manchester newspaper dedicated to the paranormal whose reporters get sucked into a battle between good and evil.

Childrens and teen

Amari and the Night Brothers by BB Alston (Egmont)Film rights have been snapped up for the first in a new supernatural adventure series with a black heroine.

Concrete Rose by Angie Thomas (Walker)From the US YA sensation, this hard-hitting prequel to the award-winning The Hate U Give focuses on Starrs father as a young man.

Poetry

Living Weapon by Rowan Ricardo Phillips (Faber)The award-winning American essayist and poets first collection to be published in the UK combines civic awareness with an interrogation of language and self.

Nonfiction

A Swim in a Pond in the Rain by George Saunders (Bloomsbury)The Booker-winning author of Lincoln in the Bardo considers the art of fiction through seven classic Russian short stories by Chekhov, Turgenev, Tolstoy and Gogol.

Francis Bacon: Revelations by Mark Stevens and Annalyn Swan (William Collins)A definitive biography, written with the full cooperation of the Bacon estate and with unrivalled access to the artists personal papers.

Begin Again: James Baldwins America by Eddie S Glaude Jr (Chatto & Windus)Exemplifying the resurgence of interest in Baldwin, this blend of biography, criticism and memoir with the novelist at its heart is an indictment of racial injustice in Trumps America.

Empireland: How Imperialism Has Shaped Modern Britain by Sathnam Sanghera (Viking)One of a new wave of books on British imperialism, this study, from the likable journalist and author of The Boy With the Topknot, looks at the legacy of empire from the NHS to Brexit and Covid.

Breathtaking: Inside the NHS in a Time of Pandemic by Rachel Clarke (Little, Brown)The palliative care doctor who scored a hit with her book Dear Life gives an insider account of hospital life as Covid-19 changed everything.

Saving Justice by James Comey (Macmillan)The former FBI director and author of A Higher Loyalty looks into how institutions of justice in the US were eroded during the Trump presidency.

The Unusual Suspect by Ben Machell (Canongate)The remarkable story of how a British student with Aspergers became obsessed with Robin Hood following the global financial crash, and began to rob banks.

4 Centenary of the birth of Betty Friedan, author of The Feminine Mystique.23 Bicentenary of the death of John Keats in Rome.

Fiction

Light Perpetual by Francis Spufford (Faber)The author of Golden Hill imagines the lost futures of children killed in the blitz, in a sparkling, humane panorama of miraculous everyday life.

No One Is Talking About This by Patricia Lockwood (Bloomsbury)Following her acclaimed comic memoir Priestdaddy, a fast and furious debut novel about being embedded deep in the digital world.

Mother for Dinner by Shalom Auslander (Picador)Outrageous comedy about identity politics and family ties centred on the Cannibal-American Seltzer clan.

We Are Not in the World by Conor OCallaghan (Transworld)Delayed from 2020, the examination of a father-daughter relationship by a rising Irish star.

Maxwells Demon by Steven Hall (Canongate)Long-awaited follow-up to ultra-inventive cult hit The Raw Shark Texts features a man being stalked by a fictional character.

Open Water by Caleb Azumah Nelson (Viking)Black British artists fall in love in an intense, elegant debut.

Voices of the Lost by Hoda Barakat, translated by Marilyn Booth (Oneworld)In a war-torn country, six characters share their secrets, in this international prize for Arabic fiction winner.

Childrens and teen

How to Change Everything by Naomi Klein with Rebecca Stefoff (Penguin)A guide to climate change billed as the young humans guide to protecting the planet and each other.

Nonfiction

Fall by John Preston (Viking)The author of A Very English Scandal turns his attention to the last days of disgraced media tycoon Robert Maxwell.

What Does Jeremy Think? by Suzanne Heywood (William Collins)A set of revealing insider political accounts, written up by the author after conversations with her husband, the former cabinet secretary Lord Heywood, who died of cancer aged 56 in 2018.

Consent: A Memoir by Vanessa Springora, translated by Natasha Lehrer (HarperCollins)The memoir, by the director of one of Frances leading publishing houses, of her sexual relationship as a teenager with a leading writer.

Bessie Smith by Jackie Kay (Faber)The national poet of Scotland has written a new introduction to her study of the American blues singer, whom she idolised as a young black girl growing up in Glasgow.

Keats by Lucasta Miller (Cape)A new biography in nine poems and an epitaph by the author of The Bront Myth, to coincide with the bicentenary of the poets death.

Brown Baby by Nikesh Shukla (Bluebird) A memoir from the Bristol-based editor of The Good Immigrant, which is also an exploration of how to raise a brown baby in an increasingly horrible world.

Karachi Vice by Samira Shackle (Granta) An impressive account of the inner workings of the Pakistani city, as exposed by the stories of five individuals.

The Code Breaker by Walter Isaacson (Simon & Schuster)The biographer of Leonardo da Vinci and Steve Jobs returns with a book about Crispr, the revolutionary tool that can edit DNA.

How to Avoid a Climate Disaster by Bill Gates (Allen Lane)The co-founder of Microsoft discusses the tools needed to reach net-zero greenhouse gas emissions.

Raceless by Georgina Lawton (Sphere)Reflections on identity along with recollections of growing up as a mixed-race girl raised by two white parents who pursued the untruth that the authors darker skin was the product of a so-called throwback gene.

Aftershocks by Nadia Owusu (Sceptre)A descendant of Ashanti royalty recounts growing up without a mother, travelling from country to country and feeling an absence of home her experience told through the metaphor of earthquakes.

19 Bicentenary of the birth of the explorer, linguist and author Richard Burton, who translated The One Thousand and One Nights and the Kama Sutra into English.

Fiction

Klara and the Sun by Kazuo Ishiguro (Faber)An Artificial Friend considers humanity and the meaning of love in Ishiguros first novel since winning the Nobel literature prize.

Double Blind by Edward St Aubyn (Harvill Secker)The author of the Patrick Melrose books investigates themes of inheritance, knowledge and freedom through the connections between three friends over one tumultuous year.

Transcendent Kingdom by Yaa Gyasi (Viking)This follow-up to her debut Homegoing, focusing on an immigrant Ghanaian family in the American South, has been a huge hit in the US.

Painting Time by Maylis de Kerangal, translated by Jessica Moore (MacLehose)The French author took the Wellcome science prize for her bravura novel about a heart transplant, Mend the Living; this new book is set in the world of trompe lil painting.

Hot Stew by Fiona Mozley (John Murray)Her debut Elmet made the Booker shortlist; this followup tackles money and class through the inhabitants of Londons Soho.

Kitchenly 434 by Alan Warner (White Rabbit)The Sopranos authors tale of a rock stars butler at the fag end of the 1970s promises to be Remains of the Day with cocaine and amplifiers.

The Committed by Viet Thanh Nguyen (Corsair)In the sequel to Pulitzer winner The Sympathizer, that novels conflicted spy finds himself in the underworld of 80s Paris.

The Absolute Book by Elizabeth Knox (Michael Joseph)From the New Zealand writer, a propulsive parallel-worlds fantasy epic about the power of stories and storytelling.

The Mysterious Correspondent by Marcel Proust, translated by Charlotte Mandell (Oneworld)Nine previously unseen stories illuminate a young writers development.

Names of the Women by Jeet Thayil (Cape)From Mary of Magdala to Susanna the Barren, women whose stories were suppressed in the New Testament.

Redder Days by Sue Rainsford (Doubleday)Twins in an abandoned commune prepare for apocalypse, in the follow-up to her standout debut Follow Me to Ground.

The Last House on Needless Street by Catriona Ward (Viper)A woman believes she has found the monster who snatched her younger sister as a child Full of twists and turns, this high-concept gothic horror is going to be huge.

Childrens and teen

The Wild Before by Piers Torday (Quercus)Can one hare change the world? A prequel to the Guardian prize-winning The Last Wild.

Poetry

Too Young, Too Loud, Too Different, edited by Maisie Lawrence and Rishi Dastidar (Corsair)An anthology celebrating 20 years of writers collective Malikas Poetry Kitchen, featuring work by now well-known alumni including Warsan Shire, Inua Ellams, Roger Robinson and Malika Booker herself.

Nonfiction

Beyond Order: 12 More Rules for Life by Jordan Peterson (Allen Lane)Having spent a year in rehab, the controversial Canadian psychologist, self-styled professor against political correctness follows up his global bestseller 12 Rules for Life.

Under a White Sky by Elizabeth Kolbert (Bodley Head)The Pulitzer prize-winning writer of The Sixth Extinction meets scientists and researchers and asks: can we change nature, this time to save it?

The Soul of a Woman: Rebel Girls, Impatient Love, and Long Life by Isabel Allende (Bloomsbury)An autobiographical meditation from the bestselling novelist on feminism and what women want.

New Yorkers by Craig Taylor (John Murray) The sequel to Taylors bestselling Londoners is another work of oral history, 10 years in the writing and drawing on hundreds of interviews.

The Diaries of Chips Channon, Volume 1: 1918-1938 edited by Simon Heffer (Hutchinson)The unexpurgated version of the often-quoted diaries of Henry Channon, social climber and Tory MP, who liked to gossip about politics and London society.

A Little Devil in America by Hanif Abdurraqib (Allen Lane)From Josephine Baker to Beyonc reflections on black performance from the author of a superb book on A Tribe Called Quest.

Inventory of a Life Mislaid by Marina Warner (William Collins)A memoir from the writer known for her books on feminism, myth and fairytales, which is structured around objects, from her mothers wedding ring to a 1952 film cylinder.

Friends by Robin Dunbar (Little, Brown)An exploration of friendship by the anthropologist and evolutionary psychologist known for the Dunbar Number, his theory that we can have meaningful relationships with only 150 people.

The Gun, the Ship and the Pen by Linda Colley (Profile) The historian best known for Britons retells modern history by considering the spread of written constitutions.

Failures of State by Jonathan Calvert and George Arbuthnot (Mudlark) Investigative journalists explore all the things the British government got wrong over Covid.

9 Bicentenary of the birth of the influential French poet, translator and critic Charles Baudelaire, author of Les Fleurs du Mal.

Fiction

Lean Fall Stand by Jon McGregor (4th Estate)An inquiry into the meaning of courage in the aftermath of a disastrous Antarctic research expedition, following the Costa-winning Reservoir 13.

My Phantoms by Gwendoline Riley (Granta)Fearless, darkly witty novel anatomising a toxic mother-daughter relationship.

Civilisations by Laurent Binet, translated by Sam Taylor (Harvill Secker)A counterfactual history of the modern world from the author of HHhH, examining the urge for power across time and space.

The High House by Jessie Greengrass (Swift)Sight was shortlisted for the Womens prize in 2018; in Greengrasss second novel, an ordinary family prepares for climate catastrophe.

This One Sky Day by Leone Ross (Faber)Set on a magical archipelago, a big, carnivalesque novel that takes on desire, addiction and postcolonialism, but is also a celebration of food, love and joy.

First Person Singular by Haruki Murakami, translated by Philip Gabriel (Harvill Secker)A new collection of eight stories that play with the boundary between memoir and fiction.

Hummingbird Salamander by Jeff VanderMeer (4th Estate)A climate change conspiracy thriller about ecoterrorism and extinction.

The Republic of False Truths by Alaa Al Aswany (Faber)A polyphonic novel about the 2011 Egyptian revolution.

Male Tears by Benjamin Myers (Bloomsbury)Farmers, boxers, ex-cons Short stories about men and masculinity.

Monsters by Barry Windsor-Smith (Cape)The US army runs a secret genetics programme in this epic graphic novel from the Marvel and Conan artist, 35 years in the making.

You Love Me by Caroline Kepnes (Simon & Schuster) The latest in the thriller series behind Netflix stalker blockbuster You.

Childrens and teen

Weirdo by Zadie Smith and Nick Laird, illustrated by Magenta Fox (Puffin)This first picture book from the husband and wife writers celebrates the quiet power of being different through the story of a guinea pig in a judo suit.

Bone Music by David Almond (Hodder)The Skellig authors new novel focuses on a young girl who moves from Newcastle to rural Northumberland and finds herself rewilded.

Poetry

A God at the Door by Tishani Doshi (Bloodaxe)The witty, wise and clear-eyed novelist, dancer and poet deploys both rage and sharp analysis covering issues from the precarious state of the environment to the treatment of women.

A Blood Condition by Kayo Chingonyi (Chatto & Windus)The second collection from the Dylan Thomas prize-winner explores both the personal and cultural influences of inheritance.

Nonfiction

Philip Roth: The Biography by Blake Bailey (Jonathan Cape)Renowned biographer Bailey was appointed by the American novelist, who died in 2018, and granted independence and complete access to the archive.

Go Big: How To Fix Our World by Ed Miliband (Bodley Head)Inspired by his Reasons to be Cheerful podcast, the shadow cabinet member investigates 20 transformative solutions to problems as intractable as inequality and the climate crisis.

How to Love Animals in a Human-Shaped World by Henry Mance (Jonathan Cape)Tapping into new thinking about animals and our changing perception of them, the FT journalist works in an abattoir, talks to chefs and philosophers and looks to a better future.

The rest is here:
2021 in books: what to look forward to this year - The Guardian